Loading flash feed…
Age verification
Nicotine is a highly addictive substance. You must be 18 or older to enter. Please confirm your age.
7×24 coverage of regulation, M&A, market data, and brand moves. Sourced, timestamped, tagged by region. No opinion. Just signal.
Haypp's report indicates 95% of UK ex-smokers feel better after switching to nicotine pouches.
FDA grants Zyn first nicotine pouch MRTP orders for 20 products, citing reduced risks.
A Haypp Group report indicates 46% of nicotine pouch users cited quitting smoking or vaping as a primary motivation for adoption.
ALP will launch online sales of its nicotine pouches in 11 international markets starting in July, targeting Europe.
British American Tobacco's Fit2Win program is on track to deliver £600 million in annual cost savings by 2028, involving global job eliminations and transfers affecting approximately 9,000 employees.
PMI and Maestro Andrea Bocelli launched 'Believe. Further' in Venice, a platform for progress and transformation.
PMI recognized by WSJ Leadership Institute for adaptability and long-term success, ranking #97 overall.
BAT to cut 9,000 global roles, targeting £600M in cost savings by 2028 via Fit2Win.
Academic study provides current estimates of tobacco and nicotine product use and cessation strategies.
Tobacco Control BMJ research details rising US oral nicotine pouch sales, excise tax analyses, and ZYN product perceptions.
FDA reviews ZYN nicotine pouch MRTP applications from Swedish Match USA.
FDA filed Modified Risk Tobacco Product applications for ZYN nicotine pouches for review.
FDA initiated substantive review of Swedish Match USA's ZYN nicotine pouch MRTP applications.
FDA schedules Jan 22, 2026, virtual TPSAC meeting for ZYN nicotine pouch MRTP applications.
FDA schedules virtual TPSAC meeting on Jan 22, 2026, to review ZYN nicotine pouch MRTP applications.